Sustainable Procurement & CSR News - Pharmaceutical Industry

GlaxoSmithKline and Samsung Biologics have teamed up to give GSK additional capacity to manufacture and supply its biopharmaceutical therapies.

Did you know that biopharmaceutical manufacturers must begin setting up the manufacturing supply chain for a medicine years before that medicine is even approved for use by patients? That’s a fact that is frequently overlooked by policymakers who are proposing drastic, mandated changes to pharmaceutical supply chains. Changes made to any supply chain require careful consideration and planning, as well as substantial engagement with FDA to obtain regulatory review and approval.

Building a new biopharmaceutical manufacturing facility can take 5 to 10 years, on average, before it is operational and can cost as much as $2 billion.